NDC 70518-0230

DESCOVY

Emtricitabine And Tenofovir Alafenamide Fumarate

DESCOVY is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Emtricitabine; Tenofovir Alafenamide Fumarate.

Product ID70518-0230_8312635b-e182-4447-e053-2a91aa0a4b04
NDC70518-0230
Product TypeHuman Prescription Drug
Proprietary NameDESCOVY
Generic NameEmtricitabine And Tenofovir Alafenamide Fumarate
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2019-02-16
Marketing CategoryNDA / NDA
Application NumberNDA208215
Labeler NameREMEDYREPACK INC.
Substance NameEMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
Active Ingredient Strength200 mg/1; mg/1
Pharm ClassesNucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 70518-0230-0

30 TABLET in 1 BLISTER PACK (70518-0230-0)
Marketing Start Date2017-02-16
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70518-0230-0 [70518023000]

DESCOVY TABLET
Marketing CategoryNDA
Application NumberNDA208215
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-02-16

Drug Details

Active Ingredients

IngredientStrength
EMTRICITABINE200 mg/1

OpenFDA Data

SPL SET ID:eccee400-e198-4071-92a8-39c51948f699
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1747697
  • 1747691
  • Pharmacological Class

    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

    NDC Crossover Matching brand name "DESCOVY" or generic name "Emtricitabine And Tenofovir Alafenamide Fumarate"

    NDCBrand NameGeneric Name
    61958-2002DESCOVYemtricitabine and tenofovir alafenamide
    61958-2005DESCOVYemtricitabine and tenofovir alafenamide
    70518-0230DESCOVYemtricitabine and tenofovir alafenamide fumarate

    Trademark Results [DESCOVY]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    DESCOVY
    DESCOVY
    86170326 4876632 Live/Registered
    Gilead Sciences Ireland UC
    2014-01-20

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.